학술논문
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal (PharmacoEconomics, (2022), 40, 9, (851-861), 10.1007/s40273-022-01166-2)
Document Type
Erratum
Author
Source
In: PharmacoEconomics . (PharmacoEconomics, November 2023, 41(11):1551)
Subject
Language
English
ISSN
11792027
11707690
11707690